Risk profiling patients for selective use of drug-eluting stents is warranted
Nat Clin Pract Cardiovasc Med
.
2007 Jul;4(7):346-7.
doi: 10.1038/ncpcardio0910.
Epub 2007 May 22.
Authors
Michael E Farkouh
1
,
Sameer Bansilal
,
Valentin Fuster
Affiliation
1
Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029 USA.
[email protected]
PMID:
17519913
DOI:
10.1038/ncpcardio0910
No abstract available
MeSH terms
Angioplasty, Balloon, Coronary
Coronary Restenosis / etiology*
Drug Delivery Systems
Humans
Myocardial Infarction / etiology
Risk Assessment*
Stents / adverse effects*